Follow the Alembic Pharmaceuticals Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Alembic Pharmaceuticals Limited has logged 34 reports. Market capitalisation: €156.7bn. The latest transaction was filed on 30 September 2025 (Purchase). Among the most active insiders: Chirayu Ramanbhai Amin HUF. Every trade is accessible without an account.
34
Insider Decl.
n/a
Thresholds
€5m
32 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alembic Pharmaceuticals Limited Buy (bullish), based on 10 analysts. Average price target: ₹918.20.
18Σ signal
Buys €5mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,881 of 29,063 companies
59.5
score / 100
Value
48
Quality
71
FCF yld1.8%
Earn yld4.3%
EV/EBITDA15.5x
ROE12%
Gross mgn67%
Net mgn9.4%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Alembic Pharmaceuticals Limited es una empresa farmacéutica con sede en la India que se especializa en la fabricación de medicamentos genéricos y productos farmacéuticos. Cotiza en la Bolsa de Bombay.